When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 10 Mar 2025
Last updated: 28 Oct 2024

Summary

Your Organisational Guidance

ebpracticenet urges you to prioritise the following organisational guidance:

Richtlijn acute rinosinusitisPublished by: Werkgroep Ontwikkeling Richtlijnen Eerste Lijn (Worel)Last published: 2023Guide de pratique clinique rhinosinusite aiguëPublished by: Groupe de travail Développement de recommandations de première ligneLast published: 2023

Definition

History and exam

Key diagnostic factors

  • symptoms <10 days (acute viral rhinosinusitis)
  • symptoms >10 days but <4 weeks (acute bacterial rhinosinusitis)
  • symptoms that worsen after an initial improvement (acute bacterial rhinosinusitis)
  • purulent nasal discharge
  • nasal obstruction
  • facial pain/pressure
  • severe symptoms at onset (acute bacterial rhinosinusitis)
  • dental pain

Other diagnostic factors

  • cough
  • sore throat
  • hyposmia
  • oedematous turbinate
  • fever

Risk factors

  • viral upper respiratory tract infection
  • allergic rhinitis

Diagnostic investigations

Investigations to consider

  • nasal endoscopy
  • sinus culture
  • CT sinuses
  • MRI
  • lateral neck x-ray
  • allergy testing

Treatment algorithm

Contributors

Authors

Gordon H. Sun, MD, MBA, MSc
Gordon H. Sun

Director of Specialty Care

High Desert Regional Health Center

Lancaster

CA

Clinical Associate Professor of Otolaryngology-Head and Neck Surgery

Charles R. Drew University of Medicine and Science

Los Angeles

CA

Disclosures

GHS is a contractor for MAXIMUS, Inc.

Acknowledgements

Dr Gordon H. Sun would like to gratefully acknowledge Dr Melissa A. Pynnonen and Dr Joseph K. Han, previous contributors to this topic.

Disclosures

MAP and JKH declare that they have no competing interests.

Peer reviewers

Michael S. Benninger, MD

Professor of Otolaryngology Head and Neck Surgery

Cleveland Clinic

Lerner College of Medicine

Cleveland

OH

Disclosures

MSB declares that he has no competing interests.

Daniel Merenstein, MD

Director of Research Family Medicine

Georgetown University

Washington, DC

Disclosures

DM declares that he has no competing interests.

Amin R. Javer, MD, FRCSC, FARS

Clinical Professor

Division of Otolaryngology

University of British Columbia

Vancouver

Canada

Disclosures

ARJ is a consultant for iView Therapeutics, GSK, and Sanofi.

Use of this content is subject to our disclaimer